These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 12424722

  • 1. Risk factors for invasive aspergillosis in liver transplant recipients.
    Fortún J, Martín-Dávila P, Moreno S, De Vicente E, Nuño J, Candelas A, Bárcena R, García M.
    Liver Transpl; 2002 Nov; 8(11):1065-70. PubMed ID: 12424722
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study.
    Gavalda J, Len O, San Juan R, Aguado JM, Fortun J, Lumbreras C, Moreno A, Munoz P, Blanes M, Ramos A, Rufi G, Gurgui M, Torre-Cisneros J, Montejo M, Cuenca-Estrella M, Rodriguez-Tudela JL, Pahissa A, RESITRA (Spanish Network for Research on Infection in Transplantation).
    Clin Infect Dis; 2005 Jul 01; 41(1):52-9. PubMed ID: 15937763
    [Abstract] [Full Text] [Related]

  • 3. Invasive aspergillosis in the recipients of liver retransplantation.
    Singh N, Pruett TL, Houston S, Muñoz P, Cacciarelli TV, Wagener MM, Husain S.
    Liver Transpl; 2006 Aug 01; 12(8):1205-9. PubMed ID: 16598780
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
    Shi SH, Lu AW, Shen Y, Jia CK, Wang WL, Xie HY, Zhang M, Liang TB, Zheng SS.
    Chin Med J (Engl); 2008 Apr 05; 121(7):625-30. PubMed ID: 18466683
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, Mendez JC, Kramer DJ, Dickson RC, Harnois DM, Spivey JR, Hughes CB, Nguyen JH, Steers JL.
    Liver Transpl; 2005 Jun 05; 11(6):656-62. PubMed ID: 15915482
    [Abstract] [Full Text] [Related]

  • 8. [Clinical analysis of aspergillosis in orthotopic liver transplant recipients].
    Liu ZW, Zou WL, Zhu XD, Zhang XL, Liu Y, Shen ZY.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar 05; 13(3):171-4. PubMed ID: 15760547
    [Abstract] [Full Text] [Related]

  • 9. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients.
    Fortún J, Martín-Davila P, Moreno S, Barcena R, de Vicente E, Honrubia A, García M, Nuño J, Candela A, Uriarte M, Pintado V.
    J Antimicrob Chemother; 2003 Nov 05; 52(5):813-9. PubMed ID: 14563893
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
    Cuellar-Rodriguez J, Avery RK, Lard M, Budev M, Gordon SM, Shrestha NK, van Duin D, Oethinger M, Mawhorter SD.
    Clin Infect Dis; 2009 Sep 01; 49(5):710-6. PubMed ID: 19635026
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for invasive aspergillosis in living donor liver transplant recipients.
    Osawa M, Ito Y, Hirai T, Isozumi R, Takakura S, Fujimoto Y, Iinuma Y, Ichiyama S, Tanaka K, Mishima M.
    Liver Transpl; 2007 Apr 01; 13(4):566-70. PubMed ID: 17394155
    [Abstract] [Full Text] [Related]

  • 13. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections.
    Badiee P, Kordbacheh P, Alborzi A, Malekhoseini S, Zeini F, Mirhendi H, Mahmoodi M.
    Liver Transpl; 2007 Jul 01; 13(7):1011-6. PubMed ID: 17600362
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for invasive fungal infections complicating orthotopic liver transplantation.
    Collins LA, Samore MH, Roberts MS, Luzzati R, Jenkins RL, Lewis WD, Karchmer AW.
    J Infect Dis; 1994 Sep 01; 170(3):644-52. PubMed ID: 8077723
    [Abstract] [Full Text] [Related]

  • 15. HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation.
    Härmä M, Höckerstedt K, Lyytikäinen O, Lautenschlager I.
    J Med Virol; 2006 Jun 01; 78(6):800-5. PubMed ID: 16628583
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Independent risk factors and natural history of renal dysfunction in liver transplant recipients.
    Pawarode A, Fine DM, Thuluvath PJ.
    Liver Transpl; 2003 Jul 01; 9(7):741-7. PubMed ID: 12827563
    [Abstract] [Full Text] [Related]

  • 18. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
    Singh N, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV.
    Liver Transpl; 2005 Jun 01; 11(6):700-4. PubMed ID: 15915496
    [Abstract] [Full Text] [Related]

  • 19. Posttransplantation dialysis-associated infections: morbidity and impact on outcome in liver transplant recipients.
    Singh N, Gayowski T, Wagener MM.
    Liver Transpl; 2001 Feb 01; 7(2):100-5. PubMed ID: 11172392
    [Abstract] [Full Text] [Related]

  • 20. Outbreak of invasive aspergillosis among renal transplant recipients.
    Panackal AA, Dahlman A, Keil KT, Peterson CL, Mascola L, Mirza S, Phelan M, Lasker BA, Brandt ME, Carpenter J, Bell M, Warnock DW, Hajjeh RA, Morgan J.
    Transplantation; 2003 Apr 15; 75(7):1050-3. PubMed ID: 12698098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.